Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin skin PK study
NCT00633997Phase 2Terminated
- Sponsor
- Novartis
- Start
- Feb 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started Feb 2008; status: terminated.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00633997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00633997.